Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review

PIK3CA Mutation in Colorectal Cancer: Relationship with Genetic and Epigenetic Alterations

(2015) Katsuhiko Nosho et al.   NEOPLASIA

Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype

(2010) K Nosho et al.   HISTOPATHOLOGY

Precision of Pyrosequencing Assay to Measure LINE-1 Methylation in Colon Cancer, Normal Colonic Mucosa, and Peripheral Blood Cells

(2010) Natsumi Irahara et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Colorectal Cancer Risk Is Not Associated with Increased Levels of Homozygosity in a Population from the United Kingdom

(2009) S. L. Spain et al.   CANCER RESEARCH

Utility of p16 Immunohistochemistry for the Identification of Lynch Syndrome

(2009) A. Paya et al.   CLINICAL CANCER RESEARCH

Tumor suppressor mechanisms in immune aging

(2009) Yan Liu et al.   CURRENT OPINION IN IMMUNOLOGY

TheMTHFRC677T and ΔDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer

(2009) Barry Iacopetta et al.   INTERNATIONAL JOURNAL OF CANCER

Aberrant p16INK4a methylation is a frequent event in colorectal cancers: prognostic value and relation to mRNA expression and immunoreactivity

(2009) Hiroyuki Mitomi et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

(2009) Arnaud D. Roth et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers

(2009) Jung Ho Kim et al.   VIRCHOWS ARCHIV

CpG island methylator phenotype (CIMP) in cancer: Causes and implications

(2008) Jens M. Teodoridis et al.   CANCER LETTERS

Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases

(2008) L. Barault et al.   CANCER RESEARCH

Epigenetic-Genetic Interactions in the APC/WNT, RAS/RAF, and P53 Pathways in Colorectal Carcinoma

(2008) Y. Suehiro et al.   CLINICAL CANCER RESEARCH

p16INK4a Is a β-Catenin Target Gene and Indicates Low Survival in Human Colorectal Tumors

(2008) Stella Wassermann et al.   GASTROENTEROLOGY

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

(2008) S. Ogino et al.   GUT

The aberrant methylation ofTSP1suppresses TGF-β1 activation in colorectal cancer

(2008) Andres Rojas et al.   INTERNATIONAL JOURNAL OF CANCER

LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer

(2008) Shuji Ogino et al.   INTERNATIONAL JOURNAL OF CANCER

Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers

(2008) Ludovic Barault et al.   INTERNATIONAL JOURNAL OF CANCER

A Cohort Study of Tumoral LINE-1 Hypomethylation and Prognosis in Colon Cancer

(2008) Shuji Ogino et al.   JNCI-Journal of the National Cancer Institute

Unknown

(2008) Yvonne Wettergren et al.   MOLECULAR MEDICINE

p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types

(2008) Alfred King-Yin Lam et al.   PATHOLOGY

Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample

(2008) Katsuhiko Nosho et al.   PLoS One

Molecular Classification and Correlates in Colorectal Cancer

(2007) Shuji Ogino et al.   JOURNAL OF MOLECULAR DIAGNOSTICS